Drug Combo Slows Progression in Advanced Breast Cancer

Results seen for alpelisib plus fulvestrant in PIK3CA - mutated, HR + , HER2 − advanced breast cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Journal, Source Type: news